Management of type 2 diabetes in the era of blood glucose sensors

Back
Michel P. Hermans Published in the journal : March 2025 Category : 19e Congrès UCLouvain d’Endocrino-Diabétologie

Summary :

Blood glucose sensors for continuous interstitial glucose monitoring are reimbursed in Belgium for certain categories of type 2 diabetics treated with basal-prandial insulin regimens under the Diabetes Convention. They provide a better assessment of glycemic exposure, allowing finer tuning of insulin doses and adjustment of non-insulin glucose-lowering medications. As with type 1 diabetes, their use requires reevaluation of dietary practices and guided dietary counseling based on ambulatory measurements as a result of improved assessment of glycemic exposure, including postprandial excursions and nocturnal glucose. 

Keywords

Type 2 diabetes, continuous glucose monitoring, HbA1c, time in range